Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study

S Epelboin, J Labrosse, J De Mouzon, P Fauque… - PLoS …, 2021 - journals.plos.org
Background To the best of our knowledge, no study has exhaustively evaluated the association
between maternal morbidities and Coronavirus Disease 2019 (COVID-19) during the …

Effectiveness of ultrasound-guided corticosteroid injection for the treatment of gluteus medius tendinopathy

JM Labrosse, É Cardinal, BE Leduc… - American Journal of …, 2010 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to evaluate the effectiveness of ultrasound-guided
corticosteroid injection for the treatment of gluteus medius tendinopathy. SUBJECTS AND …

Anti Müllerian hormone: more than a biomarker of female reproductive function

M Victoria, J Labrosse, F Krief, I Cédrin-Durnerin… - Journal of gynecology …, 2019 - Elsevier
Anti-Müllerian hormone (AMH), known for its role during sexual differentiation, is a dimeric
glycoprotein that belongs to the transforming growth factor-β (TGF-β) family. AMH has recently …

Endometriosis and assisted reproductive techniques independently related to mother–child morbidities: a French longitudinal national study

S Epelboin, J Labrosse, P Fauque, R Levy… - Reproductive …, 2021 - Elsevier
Research question Does endometriosis increase obstetric and neonatal complications, and
does assisted reproductive technology (ART) cause additional risk of maternal or fetal …

Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore

E Laas, J Labrosse, AS Hamy, G Benchimol… - British Journal of …, 2021 - nature.com
Background To compare RCB (Residual Cancer Burden) and Neo-Bioscore in terms of
prognostic performance and see if adding pathological variables improve these scores. Methods …

[HTML][HTML] Understanding follicular output rate (FORT) and its implications for POSEIDON criteria

M Grynberg, J Labrosse - Frontiers in Endocrinology, 2019 - frontiersin.org
The management of low prognosis patients in ART represents a challenge for reproductive
specialists. Different profiles and biologic characteristics have been identified among these …

Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors

…, L Laot, Y Wang, I Abdennebi, J Labrosse… - Reproductive …, 2022 - Elsevier
Research question What are the real-life oncofertility practices in young women diagnosed
with breast cancer? Design The FEERIC (FErtility, prEgnancy, contRaceptIon after breast …

Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH …

I Lalami, J Labrosse, I Cedrin-Durnerin… - Reproductive Biology …, 2022 - Springer
Background In absence of contraindication, breast cancer patients of reproductive age can
undergo fertility preservation with controlled ovarian stimulation for oocyte/embryo …

Higher risk of pre-eclampsia and other vascular disorders with artificial cycle for frozen-thawed embryo transfer compared to ovulatory cycle or to fresh embryo transfer …

S Epelboin, J Labrosse, J De Mouzon… - Frontiers in …, 2023 - frontiersin.org
Background Risks of maternal morbidity are known to be reduced in pregnancies resulting
from frozen embryo transfer (FET) compared to fresh-embryo transfer (fresh-ET), except for …

Fetal growth disorders following medically assisted reproduction: due to maternal context or techniques? A national French cohort study

…, P Fauque, MJ Gervoise-Boyer, J Labrosse… - Reproductive …, 2023 - Elsevier
Research question What part do maternal context and medically assisted reproduction (MAR)
techniques play in the risk of fetal growth disorders? Design This retrospective nationwide …